Cooper C. Collins - 03 Nov 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Cooper C. Collins
Issuer symbol
TXMD
Transactions as of
03 Nov 2025
Net transactions value
$0
Form type
4
Filing time
05 Nov 2025, 16:17:07 UTC
Previous filing
20 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Collins Cooper C. Director 951 YAMATO ROAD, SUITE 220, BOCA RATON /s/ Cooper C. Collins 05 Nov 2025 0001485508

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +8,500 $0.000000 8,500 03 Nov 2025 Common Stock 8,500 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on November 3, 2028.